- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-33-0118947

About MSP Medicines LLP
Data last updated:
MSP Medicines LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 19 June 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAE-2082. Its GSTIN is 27AABFZ4538M1ZM (Maharashtra).
The LLP has a total obligation of contribution of ₹11.36 Lakh. It is led by designated partners Sunil Haripant Pophale and Paras Vinod Gandhi.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹27.9 Cr. For the same year it recorded a net profit of ₹4.89 Cr (net margin 17.5%) and EBITDA of ₹10.38 Cr (EBITDA margin 37.2%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years and 83% over five years.
The LLP has about 98 employees on its provident fund (EPFO) records.
The LLP is associated with 1 brand: Zenvision Pharma. As per MCA filings, the LLP has open charges of ₹32.98 Cr and satisfied charges of ₹1.9 Cr on record. Court records list 7 cases involving the LLP, including 1 filed by the LLP and 6 filed against it; 4 cases are pending.
MSP Medicines LLP is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0118947). For more details, the LLP can be reached via its website zenvisionpharma.com.
Company details
Recognitions & Rankings of MSP Medicines
Contact details
MSP Medicines LLP's registered office is in Mumbai, Maharashtra. Its website is zenvisionpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1st Floor Plot No.4 K Chambers Purushottamdas Thakurdas Road Siddharth College Fort M, Umbai, Mumbai, Maharashtra, India – 400001
- IndustryPharma, Pharma Contract R&D
To see the full contact details of MSP Medicines LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
MSP Medicines operates one associated brand: Zenvision Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides pharmaceutical formulation development and contract manufacturing services globally. | zenvisionpharma.com |
Financials of MSP Medicines LLP
FY 2024 filings availableMSP Medicines LLP reported revenue of ₹27.9 Cr for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 83% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹4.89 Cr | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 17.5% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of MSP Medicines LLP, buy the company report.
Designated partners of MSP Medicines LLP
MSP Medicines has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Haripant Pophale | Designated Partner | 19 Jun 2015 | 11 Years 5 Months | Current |
| Paras Vinod Gandhi Also directs: Aarham Speciality Ingredients Private Limited | Partner | 01 Sep 2020 | 6 Years 2 Months | Current |
Peer comparison
MSP Medicines LLP is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MSP Medicines LLPthis company | ₹27.9 Cr (FY 2023) | ₹4.89 Cr | 17.5% | Mumbai, Maharashtra, India | ||
| Zieo Pharmaceuticals Private Limited | ₹10.38 Cr (FY 2025) | 37.0% | Bangalore, Karnataka, India | |||
| Li Med Labs Private Limited | ₹10.19 Cr (FY 2025) | 26.0% | Thiruvananthapuram, Kerala, India | |||
| Olene Life Sciences Private Limited | ₹10.14 Cr (FY 2025) | 169.0% | Chennai, Tamil Nadu, India | |||
| RXMD Pharmaceutical Physicians Private Limited | ₹10.13 Cr (FY 2025) | 9.0% | Chennai, Tamil Nadu, India | |||
| Sipra Labs Limited | ₹10.01 Cr (FY 2024) | -19.0% | Hydrabad, Telangana, India | |||
| Genei Laboratories Private Limited | ₹9.99 Cr (FY 2025) | -8.0% | Bangalore, Karnataka, India | |||
| Minal Specialities Private Limited | ₹9.95 Cr (FY 2025) | Ahmedabad, Gujarat, India | ||||
| KMS Health Center Private Limited | ₹9.9 Cr (FY 2024) | 3.0% | Chennai, Tamil Nadu, India | |||
| Catawba Research (India) Private Limited | ₹9.86 Cr (FY 2025) | -2.0% | Mumbai, Maharashtra, India | |||
| Vanta Bioscience Limited | ₹9.83 Cr (FY 2024) | 41.0% | Secunderabad, Telangana, India |
To see the full peer comparison of MSP Medicines LLP, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Nov 2022 | 100641945 | Bank of India | ₹31 Cr | Open | |
| 27 Sep 2021 | 100498043 | Canara Bank | ₹1.98 Cr | Open | |
| 31 May 2022 | 100631449 | Profectus Capital Private Limited | ₹1.9 Cr | Satisfied |
To see the full charge records of MSP Medicines LLP, buy the company report.
Total charge records: 3 View all charges
Legal cases
MSP Medicines LLP has 7 court cases on record: 1 filed by MSP Medicines, 6 filed against it. 4 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 4 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by Hero Fincorp Limited | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Ecl Finance Limited | Pending |
| District court, South, Delhi | Cheque dishonour complaint | Filed against the company by Godrej Finance Limited | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Protium Finance Ltd. | Disposed |
| District court, Jaipur Metro II, Rajasthan | Court case (Complaint) | Filed against the company by Clicks Capital Services Private Limited | Pending |
To see the full case history of MSP Medicines LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for MSP Medicines LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
MSP Medicines has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABFZ4538M1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of MSP Medicines LLP, buy the company report.
Recent activity
MSP Medicines LLP has 3 designated partner changes on record since 2015: 2 appointments and 1 cessation. The latest: Bobba Venkata Sivakumar ceased to be Designated Partner on 22 Jan 2026.
Frequently asked questions
MSP Medicines is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in pharma contract r and d, within the pharma industry. It was incorporated on 19 June 2015 (11+ years old) and is registered under LLPIN AAE-2082.
MSP Medicines has 2 current designated partners:
- Sunil Haripant Pophale - Designated Partner
- Paras Vinod Gandhi - Partner
The latest financial statements of MSP Medicines on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of MSP Medicines is 27AABFZ4538M1ZM, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of MSP Medicines is AAE-2082. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
MSP Medicines has 7 court cases on record: 1 filed by the LLP and 6 filed against it. 4 are pending. Most are in the district courts.
MSP Medicines was incorporated on 19 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of MSP Medicines by revenue are Zieo Pharmaceuticals Private Limited, Li Med Labs Private Limited, Olene Life Sciences Private Limited, RXMD Pharmaceutical Physicians Private Limited, Sipra Labs Limited and 5 more, all in the Pharma industry (Contract Research).
Bobba Venkata Sivakumar ceased to be Designated Partner on 22 Jan 2026. Paras Vinod Gandhi was appointed as Partner on 01 Sep 2020. Sunil Haripant Pophale was appointed as Designated Partner on 19 Jun 2015.
Yes, MSP Medicines is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-33-0118947).
MSP Medicines can be reached through the website zenvisionpharma.com. Its registered office is in Mumbai, Maharashtra, India.

